News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WENTWORTH KORY JAMES
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 6,116 shares
@ $17.9788, valued at
$110k
Sold 3,884 shares
@ $17.9979, valued at
$69.9k
Exercised 6,116 options to buy
@ $2.1, valued at
$12.8k
Exercised 3,884 options to buy
@ $2.1, valued at
$8.2k
|
|
| 06/30/2023 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Exercised 8,790 options to buy
@ $2.1, valued at
$18.5k
|
|
| 12/12/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 4,550 shares
@ $18.9534, valued at
$86.2k
Exercised 4,550 options to buy
@ $2.1, valued at
$9.6k
|
|
| 12/06/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,910 shares
@ $18.1957, valued at
$52.9k
Sold 200 shares
@ $18.05, valued at
$3.6k
Exercised 2,910 options to buy
@ $2.1, valued at
$6.1k
Exercised 200 options to buy
@ $2.1, valued at
$420 |
|
| 11/18/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 200 shares
@ $18.1, valued at
$3.6k
Exercised 200 options to buy
@ $2.1, valued at
$420 |
|
| 09/06/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 5,503 shares
@ $0 |
|
| 08/26/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,817 shares
@ $13.5226, valued at
$38.1k
Sold 301 shares
@ $14.227, valued at
$4.3k
Sold 1,551 shares
@ $14.1754, valued at
$22k
Exercised 1,117 options to buy
@ $2.1, valued at
$2.3k
|
|
| 08/23/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 8,529 shares
@ $13.0766, valued at
$111.5k
Sold 217 shares
@ $13.0047, valued at
$2.8k
Sold 2,909 shares
@ $13.0903, valued at
$38.1k
Exercised 4,452 options to buy
@ $2.1, valued at
$9.3k
Exercised 117 options to buy
@ $2.1, valued at
$245.7
Exercised 1,403 options to buy
@ $2.1, valued at
$2.9k
|
|
| 08/18/2022 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 200 shares
@ $13, valued at
$2.6k
Sold 200 shares
@ $13.07, valued at
$2.6k
Sold 200 shares
@ $13, valued at
$2.6k
Exercised 100 options to buy
@ $2.1, valued at
$210
Exercised 100 options to buy
@ $2.1, valued at
$210
Exercised 100 options to buy
@ $2.1, valued at
$210 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2021 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 72,012 options to buy
@ $20, valued at
$1.4M
|
|
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 92 shares
@ $65.0065, valued at
$6k
Sold 62 shares
@ $65.5616, valued at
$4.1k
|
|
| 03/04/2020 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 3,900 shares
@ $0
Granted 7,800 options to buy
@ $73.84, valued at
$576k
|
|
| 01/09/2020 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 223 shares
@ $89.9712, valued at
$20.1k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 27 shares
@ $126.1135, valued at
$3.4k
Sold 17 shares
@ $127.2524, valued at
$2.2k
Sold 8 shares
@ $129.5113, valued at
$1k
Sold 9 shares
@ $131.0456, valued at
$1.2k
|
|
| 06/05/2019 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 212 shares
@ $0 |
|
| 03/04/2019 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 51 shares
@ $151.71, valued at
$7.7k
|
|
| 02/27/2019 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 208 shares
@ $150.0038, valued at
$31.2k
|
|
| 02/05/2019 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $134.63, valued at
$1.3M
|
|
| 01/30/2019 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 209 shares
@ $125.964, valued at
$26.3k
|
|
| 12/21/2018 |
4
| WENTWORTH KORY JAMES (Principal Accounting Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 388 shares
@ $103.05, valued at
$40k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|